NSU Horizons Spring 2016

19 NSU HORIZONS N ancy Klimas, M.D., has been presented with the Fifth Annual Provost’s Research and Scholarship Award. Klimas serves as director of NSU’s Institute for Neuro-Immune Medicine, professor of medicine, and chair of the Department of Clinical Immunology at NSU’s College of Osteopathic Medicine. She has achieved international recogni- tion for her research and clinical efforts in multisymptom disorders, chronic fatigue syndrome and myalgic encephalo- myelitis (CFS/ME), Gulf War illness (GWI), and fibromyalgia. The purpose of the Provost’s Research and Scholarship Award is to recognize a faculty member who has demonstrated significant achievement in support of NSU’s mission to foster scholarship, intellectual inquiry, and academic excel- lence. Research and scholarship are among NSU’s eight core values, and excellence in these areas enhances education, patient care, and public service, and develops superior scholarship. n NANCY KLIMAS HONORED WITH RESEARCH AND SCHOLARSHIP AWARD that could positively impact so many people in our global community,” said George L. Hanbury II, Ph.D., president and CEO of NSU. Karolinska Institutet is one of the largest and most prestigious medical universities in the world, consistently ranked among the top universities globally. NSU recently hired a world-class team of researchers, including Richard Jove, Ph.D., who will lead the NSU Cell Therapy Institute. Jove is best known in Florida for his decade-long work as professor and director of the Molecular Oncology Program at the Moffitt Cancer Center Research Institute in Tampa and as associate director for basic research of Moffitt’s National Cancer Institute Comprehensive Cancer Center. He also served as chair of molecular medicine and director of the Beckman Research Institute at City of Hope in Los Angeles. BioFlorida’s president and CEO, Nancy Bryan, applauded the historic collaboration: “I anticipate many new important collaborations to be formed as a result, accelerating our life science industry’s growth.” The CCR will provide wet and dry labs for many of NSU’s innovative researchers. These include a General Clinical Research Center, an outpatient facility that will provide a centralized clinical research infrastructure to benefit investi- gators in multiple disciplines; a technology incubator offering partnerships with innovative companies; and the NSU Cell Therapy Institute. The CCR will also house NSU’s Institute for Neuro-Immune Medicine; NSU’s Rumbaugh-Goodwin Institute for Cancer Research; the Emil Buehler Research Center for Engineering, Science, and Mathematics; and the U.S. Geological Survey, which partners with NSU on collabora- tive interdisciplinary research involving greater Everglades restoration efforts, hydrology, water resources, and more. In addition to the CCR, Hospital Corporation of America (HCA) East Florida opened an emergency room on NSU’s Fort Lauderdale/Davie Campus in May 2015. The facility will serve as the cornerstone of the future relocation of Plantation General Hospital to the same site, by HCA East Florida. The 200-bed hospital will serve the surrounding community and eventually be a teaching and research facility integrated with NSU’s clinics, research centers, and clinical trials. n